Tango Therapeutics Inc.
TNGX | NASDAQ
$22.33
+$0.58 (+2.67%)
At close: Sep 21, 2026, 4:00 PM ET
$22.75
+$0.42 (+1.88%)
Pre-market:
Sep 22, 2026, 5:53 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -10.18 | -2.60 | -9.17 | -5.89 | -11.64 | -7.06 |
PEG Ratio | 0.38 | -0.25 | 0.75 | -0.19 | 0.28 | -2.22 |
PS Ratio | 16.50 | 8.02 | 25.63 | 25.61 | 18.34 | 130.71 |
PB Ratio | 2.97 | 1.69 | 3.70 | 2.55 | 1.97 | 25.93 |
P/FCF Ratio | -7.36 | -2.55 | -7.83 | -5.45 | -11.07 | 14.51 |
P/OCF Ratio | -7.41 | -2.57 | -7.94 | -5.84 | -11.41 | 14.28 |
OCF/S Ratio | -222.63 | -312.58 | -323 | -438.78 | -160.70 | 915.28 |
Debt / Equity Ratio | 0.10 | 0.18 | 0.15 | 0.16 | 0 | 0.20 |
Quick Ratio | 16.32 | 6.98 | 7.54 | 6.76 | 12.10 | 4.73 |
Current Ratio | 16.32 | 6.98 | 7.54 | 6.76 | 12.10 | 4.73 |
Asset Turnover | 0.16 | 0.13 | 0.09 | 0.06 | 0.07 | 0.04 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -29.35% | -65.31% | -40.20% | -43.36% | -16.89% | -134.64% |
Return on Assets | -25.48% | -41.17% | -25.27% | -24.78% | -11.64% | -25.08% |
Return on Invested Capital | -29.31% | -51.85% | -31.83% | -29.02% | -12.62% | -31.20% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 96.34% | 100% | 100% | 100% | 100% | 78.77% |
Net Profit Margin | -162.85% | -309.73% | -278.54% | -435.14% | -157.21% | -678.84% |
Pretax Profit Margin | -162.85% | -309.24% | -278.18% | -434.92% | -156.43% | -678.84% |
Operating Profit Margin | -178.39% | -346.09% | -312.57% | -446.79% | -157.09% | -681.82% |
FCF Margin | -224.31% | -314.38% | -327.18% | -469.72% | -165.66% | 900.84% |
EBITDA Margin | -159.19% | -303.30% | -271.57% | -428.46% | -154% | -657.61% |
Add to Watchlist
Select watchlists to add or remove TNGX